1222 related articles for article (PubMed ID: 28130788)
1. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Dulai PS; Singh S; Patel J; Soni M; Prokop LJ; Younossi Z; Sebastiani G; Ekstedt M; Hagstrom H; Nasr P; Stal P; Wong VW; Kechagias S; Hultcrantz R; Loomba R
Hepatology; 2017 May; 65(5):1557-1565. PubMed ID: 28130788
[TBL] [Abstract][Full Text] [Related]
2. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
Ekstedt M; Hagström H; Nasr P; Fredrikson M; Stål P; Kechagias S; Hultcrantz R
Hepatology; 2015 May; 61(5):1547-54. PubMed ID: 25125077
[TBL] [Abstract][Full Text] [Related]
4. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
[TBL] [Abstract][Full Text] [Related]
5. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
[TBL] [Abstract][Full Text] [Related]
6. SAF score and mortality in NAFLD after up to 41 years of follow-up.
Hagström H; Nasr P; Ekstedt M; Kechagias S; Stål P; Bedossa P; Hultcrantz R
Scand J Gastroenterol; 2017 Jan; 52(1):87-91. PubMed ID: 27616339
[TBL] [Abstract][Full Text] [Related]
7. Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Ng CH; Lim WH; Hui Lim GE; Hao Tan DJ; Syn N; Muthiah MD; Huang DQ; Loomba R
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):931-939.e5. PubMed ID: 35513235
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
[TBL] [Abstract][Full Text] [Related]
9. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
10. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
[TBL] [Abstract][Full Text] [Related]
11. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
[TBL] [Abstract][Full Text] [Related]
13. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis.
Pan X; Han Y; Zou T; Zhu G; Xu K; Zheng J; Zheng M; Cheng X
Dig Dis; 2018; 36(6):427-436. PubMed ID: 30048963
[TBL] [Abstract][Full Text] [Related]
15. Simple non-invasive scoring systems and histological scores in predicting mortality in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Liu CH; Ampuero J; Pavlides M; Wong VW; Fan JG; Bai L; Li H; Wu DB; Zhou LY; Du LY; Yang TK; Jiang W; Shi Y; Gil-Gómez A; Zhang WT; Liang JX; Romero-Gómez M; Tang H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1754-1768. PubMed ID: 33569851
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
Le MH; Devaki P; Ha NB; Jun DW; Te HS; Cheung RC; Nguyen MH
PLoS One; 2017; 12(3):e0173499. PubMed ID: 28346543
[TBL] [Abstract][Full Text] [Related]
17. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure.
Valbusa F; Agnoletti D; Scala L; Grillo C; Arduini P; Bonapace S; Calabria S; Scaturro G; Mantovani A; Zoppini G; Turcato E; Maggioni AP; Arcaro G; Targher G
Int J Cardiol; 2018 Aug; 265():162-168. PubMed ID: 29739707
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
20. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
